nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—PTGIR—hindbrain—Parkinson's disease	0.0232	0.0785	CbGeAlD
Alprostadil—PTGIR—brainstem—Parkinson's disease	0.0133	0.045	CbGeAlD
Alprostadil—PTGIR—forebrain—Parkinson's disease	0.0128	0.0434	CbGeAlD
Alprostadil—PTGER1—head—Parkinson's disease	0.0119	0.0403	CbGeAlD
Alprostadil—PTGER1—nervous system—Parkinson's disease	0.0113	0.0382	CbGeAlD
Alprostadil—PTGER1—central nervous system—Parkinson's disease	0.0108	0.0368	CbGeAlD
Alprostadil—PTGIR—cardiovascular system—Parkinson's disease	0.0108	0.0367	CbGeAlD
Alprostadil—PTGIR—spinal cord—Parkinson's disease	0.00826	0.028	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—Parkinson's disease	0.00817	0.0277	CbGeAlD
Alprostadil—SLCO2B1—forebrain—Parkinson's disease	0.00802	0.0272	CbGeAlD
Alprostadil—SLCO3A1—midbrain—Parkinson's disease	0.00747	0.0253	CbGeAlD
Alprostadil—ABCC5—medulla oblongata—Parkinson's disease	0.0074	0.0251	CbGeAlD
Alprostadil—PTGIR—head—Parkinson's disease	0.00734	0.0249	CbGeAlD
Alprostadil—SLCO3A1—spinal cord—Parkinson's disease	0.00729	0.0247	CbGeAlD
Alprostadil—ABCC4—forebrain—Parkinson's disease	0.0071	0.0241	CbGeAlD
Alprostadil—PTGIR—nervous system—Parkinson's disease	0.00696	0.0236	CbGeAlD
Alprostadil—ABCC5—midbrain—Parkinson's disease	0.00676	0.0229	CbGeAlD
Alprostadil—PTGIR—central nervous system—Parkinson's disease	0.0067	0.0227	CbGeAlD
Alprostadil—PTGIR—cerebellum—Parkinson's disease	0.00655	0.0222	CbGeAlD
Alprostadil—SLCO3A1—head—Parkinson's disease	0.00648	0.022	CbGeAlD
Alprostadil—SLCO2A1—head—Parkinson's disease	0.00641	0.0217	CbGeAlD
Alprostadil—SLCO3A1—nervous system—Parkinson's disease	0.00614	0.0208	CbGeAlD
Alprostadil—SLCO2A1—nervous system—Parkinson's disease	0.00608	0.0206	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—Parkinson's disease	0.00591	0.02	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—Parkinson's disease	0.00585	0.0198	CbGeAlD
Alprostadil—SLCO2B1—medulla oblongata—Parkinson's disease	0.00579	0.0196	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—Parkinson's disease	0.00578	0.0196	CbGeAlD
Alprostadil—PTGIR—brain—Parkinson's disease	0.00532	0.018	CbGeAlD
Alprostadil—ABCC5—cerebellum—Parkinson's disease	0.00523	0.0177	CbGeAlD
Alprostadil—SLCO2B1—spinal cord—Parkinson's disease	0.00517	0.0175	CbGeAlD
Alprostadil—SLCO3A1—brain—Parkinson's disease	0.00469	0.0159	CbGeAlD
Alprostadil—SLCO2A1—brain—Parkinson's disease	0.00465	0.0158	CbGeAlD
Alprostadil—SLCO2B1—head—Parkinson's disease	0.00459	0.0156	CbGeAlD
Alprostadil—SLCO2B1—nervous system—Parkinson's disease	0.00435	0.0148	CbGeAlD
Alprostadil—ABCC5—brain—Parkinson's disease	0.00425	0.0144	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—Parkinson's disease	0.00419	0.0142	CbGeAlD
Alprostadil—SLCO2B1—cerebellum—Parkinson's disease	0.0041	0.0139	CbGeAlD
Alprostadil—ABCC4—head—Parkinson's disease	0.00407	0.0138	CbGeAlD
Alprostadil—ABCC4—nervous system—Parkinson's disease	0.00385	0.0131	CbGeAlD
Alprostadil—ABCC4—central nervous system—Parkinson's disease	0.00371	0.0126	CbGeAlD
Alprostadil—SLCO2B1—brain—Parkinson's disease	0.00333	0.0113	CbGeAlD
Alprostadil—ABCC4—brain—Parkinson's disease	0.00295	0.00999	CbGeAlD
Alprostadil—Ethanolamine Oleate—CYP2E1—Parkinson's disease	0.00249	1	CrCbGaD
Alprostadil—ABCC5—Metabolism—MCCC1—Parkinson's disease	0.00105	0.0015	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ND3—Parkinson's disease	0.00105	0.0015	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00105	0.00149	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—GRM4—Parkinson's disease	0.00105	0.00149	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GRM4—Parkinson's disease	0.00105	0.00149	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAG—Parkinson's disease	0.00103	0.00147	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR7—Parkinson's disease	0.00103	0.00146	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR7—Parkinson's disease	0.00103	0.00146	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—DRD2—Parkinson's disease	0.00103	0.00146	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—DRD2—Parkinson's disease	0.00103	0.00146	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00102	0.00146	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GRK5—Parkinson's disease	0.00102	0.00146	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00102	0.00145	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00101	0.00143	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PDYN—Parkinson's disease	0.001	0.00143	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PDYN—Parkinson's disease	0.001	0.00143	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—TAC1—Parkinson's disease	0.001	0.00143	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PENK—Parkinson's disease	0.000995	0.00142	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PENK—Parkinson's disease	0.000995	0.00142	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TALDO1—Parkinson's disease	0.000989	0.00141	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—OMD—Parkinson's disease	0.000989	0.00141	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000982	0.0014	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000978	0.00139	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TAF1—Parkinson's disease	0.000952	0.00135	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FBP1—Parkinson's disease	0.000952	0.00135	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000951	0.00135	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000946	0.00135	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000946	0.00135	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000938	0.00134	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NDUFB11—Parkinson's disease	0.000938	0.00133	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—GRM5—Parkinson's disease	0.000931	0.00133	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000931	0.00133	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000924	0.00131	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GRM4—Parkinson's disease	0.000917	0.00131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DGKQ—Parkinson's disease	0.000912	0.0013	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GPR37—Parkinson's disease	0.000912	0.0013	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GPR37—Parkinson's disease	0.000912	0.0013	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DGKQ—Parkinson's disease	0.000912	0.0013	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PDYN—Parkinson's disease	0.00091	0.00129	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PDYN—Parkinson's disease	0.00091	0.00129	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—TAC1—Parkinson's disease	0.00091	0.00129	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GCH1—Parkinson's disease	0.000894	0.00127	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—DRD1—Parkinson's disease	0.000892	0.00127	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000891	0.00127	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000888	0.00126	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PENK—Parkinson's disease	0.00087	0.00124	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAG—Parkinson's disease	0.00087	0.00124	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—DRD3—Parkinson's disease	0.000864	0.00123	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00086	0.00122	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00086	0.00122	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—GRM5—Parkinson's disease	0.000846	0.0012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—GRM5—Parkinson's disease	0.000846	0.0012	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000842	0.0012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000834	0.00119	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000834	0.00119	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—EDN1—Parkinson's disease	0.000823	0.00117	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—EDN1—Parkinson's disease	0.000823	0.00117	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—SOD1—Parkinson's disease	0.000811	0.00115	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000807	0.00115	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—DBH—Parkinson's disease	0.000797	0.00113	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—FBP1—Parkinson's disease	0.000797	0.00113	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GBA—Parkinson's disease	0.000797	0.00113	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PDYN—Parkinson's disease	0.000795	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000792	0.00113	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000792	0.00113	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—DRD2—Parkinson's disease	0.000781	0.00111	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HTR7—Parkinson's disease	0.000781	0.00111	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—ABL1—Parkinson's disease	0.000774	0.0011	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—IGF2—Parkinson's disease	0.000771	0.0011	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPL6—Parkinson's disease	0.000761	0.00108	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SNCA—Parkinson's disease	0.000761	0.00108	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GFAP—Parkinson's disease	0.000748	0.00106	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GRM5—Parkinson's disease	0.00074	0.00105	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000736	0.00105	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000729	0.00104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RIT2—Parkinson's disease	0.000729	0.00104	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RIT2—Parkinson's disease	0.000729	0.00104	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—HGF—Parkinson's disease	0.000728	0.00104	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—HTR2A—Parkinson's disease	0.00072	0.00103	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00072	0.00103	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000719	0.00102	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000719	0.00102	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.0007	0.000996	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000697	0.000992	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GRK5—Parkinson's disease	0.000691	0.000983	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GRK5—Parkinson's disease	0.000691	0.000983	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000689	0.00098	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000687	0.000978	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000687	0.000978	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000678	0.000965	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—TAC1—Parkinson's disease	0.000677	0.000963	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000677	0.000963	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000669	0.000952	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—DRD1—Parkinson's disease	0.000664	0.000944	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000664	0.000944	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—FGB—Parkinson's disease	0.000651	0.000927	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF20—Parkinson's disease	0.000648	0.000923	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000643	0.000915	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—DRD3—Parkinson's disease	0.000643	0.000915	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000629	0.000895	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EDN1—Parkinson's disease	0.000626	0.00089	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000624	0.000888	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR1A—Parkinson's disease	0.000624	0.000888	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GRM4—Parkinson's disease	0.00062	0.000882	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GRM4—Parkinson's disease	0.00062	0.000882	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—TAC1—Parkinson's disease	0.000614	0.000875	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—TAC1—Parkinson's disease	0.000614	0.000875	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000608	0.000866	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000603	0.000858	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—DRD1—Parkinson's disease	0.000603	0.000858	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—DRD1—Parkinson's disease	0.000603	0.000858	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0006	0.000854	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0006	0.000854	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PENK—Parkinson's disease	0.000588	0.000836	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PENK—Parkinson's disease	0.000588	0.000836	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAG—Parkinson's disease	0.000588	0.000836	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAG—Parkinson's disease	0.000588	0.000836	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—DDC—Parkinson's disease	0.000585	0.000833	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000584	0.000831	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—DRD3—Parkinson's disease	0.000584	0.000831	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—DRD3—Parkinson's disease	0.000584	0.000831	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000581	0.000828	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR7—Parkinson's disease	0.000581	0.000827	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000581	0.000827	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000581	0.000827	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—DRD2—Parkinson's disease	0.000581	0.000827	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INSR—Parkinson's disease	0.00058	0.000826	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPL23A—Parkinson's disease	0.000577	0.000821	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPL14—Parkinson's disease	0.000577	0.000821	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000558	0.000794	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTA4—Parkinson's disease	0.000553	0.000787	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGB—Parkinson's disease	0.000548	0.000781	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000547	0.000779	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR1A—Parkinson's disease	0.000546	0.000777	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000545	0.000776	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000545	0.000776	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF20—Parkinson's disease	0.000538	0.000766	CbGpPWpGaD
Alprostadil—ABCC5—Disease—RPS8—Parkinson's disease	0.000538	0.000766	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PDYN—Parkinson's disease	0.000537	0.000765	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PDYN—Parkinson's disease	0.000537	0.000765	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TAC1—Parkinson's disease	0.000537	0.000765	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR7—Parkinson's disease	0.000528	0.000751	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—DRD2—Parkinson's disease	0.000528	0.000751	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—DRD2—Parkinson's disease	0.000528	0.000751	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR7—Parkinson's disease	0.000528	0.000751	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DRD1—Parkinson's disease	0.000527	0.00075	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DRD3—Parkinson's disease	0.00051	0.000726	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GFAP—Parkinson's disease	0.000505	0.000719	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GFAP—Parkinson's disease	0.000505	0.000719	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GRM5—Parkinson's disease	0.0005	0.000711	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GRM5—Parkinson's disease	0.0005	0.000711	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PLA2G6—Parkinson's disease	0.000498	0.000708	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MAOB—Parkinson's disease	0.000493	0.000701	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SOD1—Parkinson's disease	0.000484	0.000688	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000483	0.000687	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000477	0.000678	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000465	0.000662	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—EDN1—Parkinson's disease	0.000465	0.000662	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000464	0.00066	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR7—Parkinson's disease	0.000462	0.000657	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—DRD2—Parkinson's disease	0.000462	0.000657	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ABL1—Parkinson's disease	0.000461	0.000657	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF2—Parkinson's disease	0.000459	0.000654	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000443	0.000631	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF20—Parkinson's disease	0.000438	0.000623	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF20—Parkinson's disease	0.000438	0.000623	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—HGF—Parkinson's disease	0.000434	0.000617	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000425	0.000605	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADORA2A—Parkinson's disease	0.000425	0.000605	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EDN1—Parkinson's disease	0.000423	0.000601	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EDN1—Parkinson's disease	0.000423	0.000601	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000407	0.000579	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000407	0.000579	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000403	0.000574	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ADRBK1—Parkinson's disease	0.000395	0.000563	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HSPA1A—Parkinson's disease	0.000392	0.000559	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INSR—Parkinson's disease	0.000392	0.000558	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INSR—Parkinson's disease	0.000392	0.000558	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000387	0.000551	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF2—Parkinson's disease	0.000387	0.000551	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1R—Parkinson's disease	0.000374	0.000532	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGB—Parkinson's disease	0.00037	0.000527	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGB—Parkinson's disease	0.00037	0.000527	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR2A—Parkinson's disease	0.00037	0.000526	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2A—Parkinson's disease	0.00037	0.000526	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EDN1—Parkinson's disease	0.00037	0.000526	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR1A—Parkinson's disease	0.000369	0.000525	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR1A—Parkinson's disease	0.000369	0.000525	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2D6—Parkinson's disease	0.000366	0.000521	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TAC1—Parkinson's disease	0.000363	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TAC1—Parkinson's disease	0.000363	0.000517	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CTGF—Parkinson's disease	0.000359	0.000511	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DRD1—Parkinson's disease	0.000356	0.000507	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DRD1—Parkinson's disease	0.000356	0.000507	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DRD3—Parkinson's disease	0.000345	0.000491	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DRD3—Parkinson's disease	0.000345	0.000491	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGF—Parkinson's disease	0.00034	0.000483	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2E1—Parkinson's disease	0.000335	0.000477	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NQO1—Parkinson's disease	0.000331	0.000471	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TH—Parkinson's disease	0.000326	0.000464	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR2A—Parkinson's disease	0.000323	0.00046	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000322	0.000458	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000322	0.000458	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYCS—Parkinson's disease	0.000313	0.000446	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR7—Parkinson's disease	0.000312	0.000444	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR7—Parkinson's disease	0.000312	0.000444	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DRD2—Parkinson's disease	0.000312	0.000444	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DRD2—Parkinson's disease	0.000312	0.000444	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—Parkinson's disease	0.000301	0.000428	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—COMT—Parkinson's disease	0.000277	0.000395	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTP1—Parkinson's disease	0.000276	0.000393	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MAOA—Parkinson's disease	0.000275	0.000392	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—Parkinson's disease	0.000272	0.000388	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—Parkinson's disease	0.000268	0.000381	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCB1—Parkinson's disease	0.000261	0.000372	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF2—Parkinson's disease	0.000261	0.000372	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF2—Parkinson's disease	0.000261	0.000372	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—INS—Parkinson's disease	0.000257	0.000365	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—Parkinson's disease	0.000254	0.000361	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1R—Parkinson's disease	0.000253	0.00036	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1R—Parkinson's disease	0.000253	0.00036	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDN1—Parkinson's disease	0.00025	0.000355	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDN1—Parkinson's disease	0.00025	0.000355	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—Parkinson's disease	0.000249	0.000355	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPX1—Parkinson's disease	0.000243	0.000346	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—Parkinson's disease	0.000229	0.000326	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—Parkinson's disease	0.000229	0.000326	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—Parkinson's disease	0.000224	0.000319	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—Parkinson's disease	0.000218	0.000311	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—Parkinson's disease	0.000218	0.000311	CbGpPWpGaD
Alprostadil—ABCC5—Disease—INS—Parkinson's disease	0.000213	0.000303	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—Parkinson's disease	0.000209	0.000297	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—Parkinson's disease	0.000203	0.000289	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—Parkinson's disease	0.000203	0.000289	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—Parkinson's disease	0.000191	0.000272	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—Parkinson's disease	0.00019	0.00027	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—INS—Parkinson's disease	0.000178	0.000254	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK8—Parkinson's disease	0.000176	0.00025	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—INS—Parkinson's disease	0.000173	0.000247	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—INS—Parkinson's disease	0.000173	0.000247	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—Parkinson's disease	0.000129	0.000184	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—Parkinson's disease	0.000129	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—Parkinson's disease	0.000128	0.000183	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—Parkinson's disease	0.000128	0.000183	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK8—Parkinson's disease	0.000119	0.000169	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK8—Parkinson's disease	0.000119	0.000169	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—Parkinson's disease	0.000112	0.00016	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—Parkinson's disease	9.31e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—Parkinson's disease	7.58e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—Parkinson's disease	7.58e-05	0.000108	CbGpPWpGaD
